Kerem Mert Senses
Kerem Mert Senses
Assistant Professor of Molecular Biology and Genetics, Bulent Ecevit University
Verified email at
Cited by
Cited by
MicroRNA expression patterns in canine mammary cancer show significant differences between metastatic and non-metastatic tumours
M Bulkowska, A Rybicka, KM Senses, K Ulewicz, K Witt, J Szymanska, ...
BMC cancer 17, 1-17, 2017
Epigenetic mechanisms underlying the dynamic expression of cancer-testis genes, PAGE2,-2B and SPANX-B, during mesenchymal-to-epithelial transition
S Yilmaz-Ozcan, A Sade, B Kucukkaraduman, Y Kaygusuz, KM Senses, ...
PloS one 9 (9), e107905, 2014
Adjuvant autologous melanoma vaccine for macroscopic stage III disease: survival, biomarkers, and improved response to CTLA‐4 blockade
M Lotem, S Merims, S Frank, T Hamburger, A Nissan, L Kadouri, J Cohen, ...
Journal of immunology research 2016 (1), 8121985, 2016
Downregulation of DNAJC10 (ERDJ5) is associated with poor survival in breast cancer
T Acun, KM Senses
Breast Cancer 27 (3), 483-489, 2020
Cancer-testis gene expression is associated with the methylenetetrahydrofolate reductase 677 C>T polymorphism in non-small cell lung carcinoma
KM Senses, M Gonen, AR Barutcu, Z Kalaylioglu, M Isbilen, O Konu, ...
BMC Medical Genetics 14, 1-6, 2013
Phenotype-based variation as a biomarker of sensitivity to molecularly targeted therapy in melanoma
KM Senses, M Ghasemi, MW Akbar, M Isbilen, AL Fallacara, ...
Medchemcomm 8 (1), 88-95, 2017
Predicting chemotherapy sensitivity profiles for breast cancer cell lines with and without stem cell-like features
M Isbilen, K Mert Senses, A Osmay Gure
Current Signal Transduction Therapy 8 (3), 268-273, 2013
Predictive gene signature for pyrazolopyrimidine derivative c-Src inhibitor 10a sensitivity in melanoma cells
B Kucukkaraduman, C Turk, AL Fallacara, M Isbilen, KM Senses, ...
ACS Medicinal Chemistry Letters 11 (5), 928-932, 2020
DNAJC10 (ERDJ5) is a novel biomarker candidate in breast cancer.
T Acun, KM Senses
Erciyes Medical Journal 41 (S1), 17-19, 2019
Clinical Study Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade
M Lotem, S Merims, S Frank, T Hamburger, A Nissan, L Kadouri, J Cohen, ...
Predicting effective single molecule inhibitors in distinct subpopulations of melanoma
KM Senses, M Ghasemi, M Isbilen, IA Deniz, FN Arslan, A Lucia, ...
The system can't perform the operation now. Try again later.
Articles 1–11